COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.

Andrea Matucci; Marco Caminati; Emanuele Vivarelli; Andrea Vianello; Claudio Micheletto; Francesco Menzella; Ernesto Crisafulli; Giovanni Passalacqua; Diego Bagnasco; Carlo Lombardi; Paola Parronchi; Mariaangiola A. Crivellaro; Fulvia Chieco-Bianchi; Maria Rita Marchi; Gabriella Guarnieri; Lorenzo Cosmi; Oliviero Rossi; Fabio Almerigogna; Gianenrico Senna; Alessandra Vultaggio

doi:10.1111/all.14516

COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.

Andrea Matucci, Marco Caminati, Emanuele Vivarelli, Andrea Vianello, Claudio Micheletto, Francesco Menzella, Ernesto Crisafulli, Giovanni Passalacqua, Diego Bagnasco, Carlo Lombardi, Paola Parronchi, Mariaangiola A. Crivellaro, Fulvia Chieco-Bianchi, Maria Rita Marchi, Gabriella Guarnieri, Lorenzo Cosmi, Oliviero Rossi, Fabio Almerigogna, Gianenrico Senna, Alessandra Vultaggio

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Allergy: European Journal of Allergy and Clinical Immunology
DOIs	https://doi.org/10.1111/all.14516
Publication status	E-pub ahead of print - Jul 27 2020
Externally published	Yes

Keywords

asthma
biologics
infections
virus

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1111/all.14516

Cite this

Matucci, A., Caminati, M., Vivarelli, E., Vianello, A., Micheletto, C., Menzella, F., Crisafulli, E., Passalacqua, G., Bagnasco, D., Lombardi, C., Parronchi, P., Crivellaro, M. A., Chieco-Bianchi, F., Rita Marchi, M., Guarnieri, G., Cosmi, L., Rossi, O., Almerigogna, F., Senna, G., & Vultaggio, A. (2020). COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey. Allergy: European Journal of Allergy and Clinical Immunology. https://doi.org/10.1111/all.14516

COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey. / Matucci, Andrea; Caminati, Marco; Vivarelli, Emanuele; Vianello, Andrea; Micheletto, Claudio; Menzella, Francesco; Crisafulli, Ernesto; Passalacqua, Giovanni; Bagnasco, Diego; Lombardi, Carlo; Parronchi, Paola; Crivellaro, Mariaangiola A.; Chieco-Bianchi, Fulvia; Rita Marchi, Maria; Guarnieri, Gabriella; Cosmi, Lorenzo; Rossi, Oliviero; Almerigogna, Fabio; Senna, Gianenrico; Vultaggio, Alessandra.

In: Allergy: European Journal of Allergy and Clinical Immunology, 27.07.2020.

Research output: Contribution to journal › Letter › peer-review

Matucci, A, Caminati, M, Vivarelli, E, Vianello, A, Micheletto, C, Menzella, F, Crisafulli, E, Passalacqua, G, Bagnasco, D, Lombardi, C, Parronchi, P, Crivellaro, MA, Chieco-Bianchi, F, Rita Marchi, M, Guarnieri, G, Cosmi, L, Rossi, O, Almerigogna, F, Senna, G & Vultaggio, A 2020, 'COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.', Allergy: European Journal of Allergy and Clinical Immunology. https://doi.org/10.1111/all.14516

Matucci, Andrea ; Caminati, Marco ; Vivarelli, Emanuele ; Vianello, Andrea ; Micheletto, Claudio ; Menzella, Francesco ; Crisafulli, Ernesto ; Passalacqua, Giovanni ; Bagnasco, Diego ; Lombardi, Carlo ; Parronchi, Paola ; Crivellaro, Mariaangiola A. ; Chieco-Bianchi, Fulvia ; Rita Marchi, Maria ; Guarnieri, Gabriella ; Cosmi, Lorenzo ; Rossi, Oliviero ; Almerigogna, Fabio ; Senna, Gianenrico ; Vultaggio, Alessandra. / COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey. In: Allergy: European Journal of Allergy and Clinical Immunology. 2020.

@article{2c2489c8c14a484b8040f6a7ea20e612,

title = "COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.",

keywords = "asthma, biologics, infections, virus",

author = "Andrea Matucci and Marco Caminati and Emanuele Vivarelli and Andrea Vianello and Claudio Micheletto and Francesco Menzella and Ernesto Crisafulli and Giovanni Passalacqua and Diego Bagnasco and Carlo Lombardi and Paola Parronchi and Crivellaro, {Mariaangiola A.} and Fulvia Chieco-Bianchi and {Rita Marchi}, Maria and Gabriella Guarnieri and Lorenzo Cosmi and Oliviero Rossi and Fabio Almerigogna and Gianenrico Senna and Alessandra Vultaggio",

year = "2020",

month = jul,

day = "27",

doi = "10.1111/all.14516",

language = "English",

journal = "Allergy: European Journal of Allergy and Clinical Immunology",

issn = "0105-4538",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.

AU - Matucci, Andrea

AU - Caminati, Marco

AU - Vivarelli, Emanuele

AU - Vianello, Andrea

AU - Micheletto, Claudio

AU - Menzella, Francesco

AU - Crisafulli, Ernesto

AU - Passalacqua, Giovanni

AU - Bagnasco, Diego

AU - Lombardi, Carlo

AU - Parronchi, Paola

AU - Crivellaro, Mariaangiola A.

AU - Chieco-Bianchi, Fulvia

AU - Rita Marchi, Maria

AU - Guarnieri, Gabriella

AU - Cosmi, Lorenzo

AU - Rossi, Oliviero

AU - Almerigogna, Fabio

AU - Senna, Gianenrico

AU - Vultaggio, Alessandra

PY - 2020/7/27

Y1 - 2020/7/27

KW - asthma

KW - biologics

KW - infections

KW - virus

UR - http://www.scopus.com/inward/record.url?scp=85089254298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089254298&partnerID=8YFLogxK

U2 - 10.1111/all.14516

DO - 10.1111/all.14516

M3 - Letter

C2 - 32716580

AN - SCOPUS:85089254298

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

ER -

COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this